• Patients & Public

    • What is tuberculosis
    • Therapies
    • Therapy testing
    • In Silico trials

  • Clinicians

    • Adjuvant therapies
    • Clinical description

  • Industry

    • In Silico opportunity
    • Industrial partners

  • Researchers

    • In Silico World
    • Objectives
    • Papers & Publications
    • Technical Deliverables

  • Project

    • About the project
    • UISS-TB simulator
    • Member Area

  • News & Events

  • About us

    • Consortium
    • Contacts

  • More

    Use tab to navigate through the menu items.
    Logo Strituvad (1).png
    • Twitter Clean
    • Bianco LinkedIn Icon

    We are on

    • All News
    • Press Releases
    • Events
    • Newsletter
    • Interviews
    Search
    Ruti therapeutic vaccine's clinical trials: Site Initiation Visit successfully concluded last Friday
    STriTuVaD consortium
    • Sep 17
    • 1 min

    Ruti therapeutic vaccine's clinical trials: Site Initiation Visit successfully concluded last Friday

    290
    Combine group’s integrated bioinformatics pipeline predicts the response of human immune system
    STriTuVaD consortium
    • Sep 13
    • 3 min

    Combine group’s integrated bioinformatics pipeline predicts the response of human immune system

    230
    Tuberculosis: clinical trial for RUTI adjuvant vaccine to start in August 2021
    STriTuVaD consortium
    • Aug 11
    • 1 min

    Tuberculosis: clinical trial for RUTI adjuvant vaccine to start in August 2021

    220
    1
    2
    345

    © 2018-2023 STRITUVAD

    • Twitter Clean
    • Bianco LinkedIn Icon